P-NADs: PUX-based NAnobody Degraders for Ubiquitin-Independent Degradation of Target Proteins
Wang, J.; Chistov, G.; Zhang, J.; Huntington, B.; Salem, I.; Sandholu, A.; Arold, S. T.
Show abstract
Targeted protein degradation (TPD) allows cells to maintain a functional proteome and to rapidly adapt to changing conditions. Methods that repurpose TPD for the deactivation of specific proteins have demonstrated significant potential in therapeutic and research applications. Most of these methods are based on proteolysis targeting chimaera (PROTAC) which link the protein target to an E3 ubiquitin ligase binding moiety, resulting in the ubiquitin-based degradation of the target protein. In this study, we introduce a method for ubiquitin-independent TPD based on nanobody-conjugated plant ubiquitin regulatory X domain-containing (PUX) adaptor proteins. We show that the PUX-based NAnobody Degraders (P-NADs) can unfold a target protein through the Arabidopsis and human orthologues of the CDC48 unfoldase without the need for ubiquitination or initiating motifs. Despite originating from plants, P-NAD plasmids can be transfected into a human cell line, where produced proteins use the endogenous CDC48 machinery for ubiquitin-independent TPD. Thus, P-NADs pave the road for ubiquitin-independent therapeutic TPD approaches. The P-NAD design combined with established in vitro and cellular assays make this system also a versatile platform for elucidating functional aspects of CDC48-based TPD in plants and animals.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Single-molecule observations of human small heat shock proteins in complex with aggregation-prone client proteins 94%
- A novel polyubiquitin chain linkage formed by viral Ubiquitin prevents cleavage by deubiquitinating enzymes 93%
- Non-conservation of folding rates in the thioredoxin family reveals degradation of ancestral unassisted-folding 92%
Similar papers in this journal
Similar papers in this journal
- Protein engineering approach to enhance activity assays of mono-ADP-ribosyltransferases through proximity 93%
- CDRxAbs: Antibody Small-Molecule Conjugates with Computationally Designed Target-Binding Synergy 91%
- Modular and integrative activity reporters enhance biochemical studies in the yeast ER. 91%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.